Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection

Metabolic adaptation to the host niche is a defining feature of the pathogenicity of Mycobacterium tuberculosis (Mtb). In vitro, Mtb is able to grow on a variety of carbon sources, but mounting evidence has implicated fatty acids as the major source of carbon and energy for Mtb during infection. When bacterial metabolism is primarily fueled by fatty acids, biosynthesis of sugars from intermediates of the tricarboxylic acid cycle is essential for growth. The role of gluconeogenesis in the pathogenesis of Mtb however remains unaddressed. Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the first committed step of gluconeogenesis. We applied genetic analyses and 13C carbon tracing to confirm that PEPCK is essential for growth of Mtb on fatty acids and catalyzes carbon flow from tricarboxylic acid cycle–derived metabolites to gluconeogenic intermediates. We further show that PEPCK is required for growth of Mtb in isolated bone marrow–derived murine macrophages and in mice. Importantly, Mtb lacking PEPCK not only failed to replicate in mouse lungs but also failed to survive, and PEPCK depletion during the chronic phase of infection resulted in mycobacterial clearance. Mtb thus relies on gluconeogenesis throughout the infection. PEPCK depletion also attenuated Mtb in IFNγ-deficient mice, suggesting that this enzyme represents an attractive target for chemotherapy.

[1]  G. Kaplan,et al.  The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro , 2007, Molecular microbiology.

[2]  S. Fischer,et al.  Analysis of hydrophilic metabolites by high-performance liquid chromatography-mass spectrometry using a silica hydride-based stationary phase. , 2008, Journal of chromatography. A.

[3]  E. Muñoz-Elías,et al.  Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence , 2006, Molecular microbiology.

[4]  Sabine Ehrt,et al.  Improved tetracycline repressors for gene silencing in mycobacteria , 2009, Nucleic acids research.

[5]  Uwe Sauer,et al.  The PEP-pyruvate-oxaloacetate node as the switch point for carbon flux distribution in bacteria. , 2005, FEMS microbiology reviews.

[6]  H Sahm,et al.  Metabolic consequences of altered phosphoenolpyruvate carboxykinase activity in Corynebacterium glutamicum reveal anaplerotic regulation mechanisms in vivo. , 2001, Metabolic engineering.

[7]  Christopher T. Walsh,et al.  Antibiotics for Emerging Pathogens , 2009, Science.

[8]  R. Hanson Thematic Minireview Series: A Perspective on the Biology of Phosphoenolpyruvate Carboxykinase 55 Years After Its Discovery* , 2009, The Journal of Biological Chemistry.

[9]  William R. Jacobs,et al.  Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice , 1999, Nature.

[10]  L. Delbaere,et al.  Structure and Mechanism of Phosphoenolpyruvate Carboxykinase* , 1997, The Journal of Biological Chemistry.

[11]  Matthew J. Brauer,et al.  Conservation of the metabolomic response to starvation across two divergent microbes , 2006, Proceedings of the National Academy of Sciences.

[12]  Sabine Ehrt,et al.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor , 2005, Nucleic acids research.

[13]  K. Pethe,et al.  Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. , 2010, Microbiology.

[14]  D. Russell,et al.  pckA-deficient Mycobacterium bovis BCG shows attenuated virulence in mice and in macrophages. , 2003, Microbiology.

[15]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[16]  Yang Liu,et al.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages , 2003, The Journal of experimental medicine.

[17]  J. Mckinney,et al.  Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. , 2007, Microbiology.

[18]  E. Muñoz-Elías,et al.  Carbon metabolism of intracellular bacteria , 2006, Cellular microbiology.

[19]  Gilla Kaplan,et al.  Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Clifton E. Barry,et al.  Tuberculosis — metabolism and respiration in the absence of growth , 2005, Nature Reviews Microbiology.

[21]  H. Nikaido,et al.  The envelope of mycobacteria. , 1995, Annual review of biochemistry.

[22]  James C Sacchettini,et al.  Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis , 2006, Molecular microbiology.

[23]  B. Mukhopadhyay,et al.  A GTP-dependent Vertebrate-type Phosphoenolpyruvate Carboxykinase from Mycobacterium smegmatis * , 2001, The Journal of Biological Chemistry.

[24]  B. Gicquel,et al.  Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature‐tagged transposon mutagenesis , 1999, Molecular microbiology.

[25]  C. Barry,et al.  Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. , 2001, Trends in microbiology.

[26]  W. Jacobs,et al.  Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Segal,et al.  BIOCHEMICAL DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS GROWN IN VIVO AND IN VITRO , 1956, Journal of bacteriology.

[28]  E. Muñoz-Elías,et al.  Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence , 2005, Nature Medicine.

[29]  T. Wilson,et al.  Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures. , 2002, Microbiology.

[30]  W. Hillen,et al.  In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice , 2007, Nature Medicine.

[31]  I. Smith,et al.  Mycobacterium tuberculosis gene expression in macrophages. , 2003, Microbes and infection.

[32]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[33]  M. Reed,et al.  Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies. , 2009, Microbiology.

[34]  J. Norton,et al.  Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Sabine Ehrt,et al.  Acid Resistance in Mycobacterium tuberculosis , 2009, Journal of bacteriology.

[36]  Digby F. Warner,et al.  Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids , 2008, Journal of bacteriology.